NCT01524848 - Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

November 30, 2016

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG

Pazopanib

Two (2) tablets of 400 mg given once daily continuously

Trial Locations (16)

Herlev Hospital, dept. of Oncology, Herlev

Klinik für Interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg, Berlin

Aarhus University Hospital, dept. of Oncology, Aarhus

Helsinki University Hospital, dept. of oncology, Helsingfors

Kuopio University Hospital Cancer Center, Kuopio

Universitätsklinikum Essen, Innere klinik und Poliklinik, Essen

Studienzentrale chirurgische klinik, Universitäts medizin Mannheim, Mannheim

Dept of Oncology, Haukeland University Hospital, Bergen

Norwegian Radium Hospital, Oslo

Dept of Oncology, St Olav Hospital, Trondheim

Dept of Oncology, Sahlgrenska University Hospital, Gothenburg

Dept of Oncology, Linköping University Hospital, Linköping

Dept of Oncology, Skane University Hospital, Lund

Radiumhemmet, Karolinska University Hospital, Stockholm

Dept of Oncology, Norrland University Hospital, Umeå

Dept of Oncology, Academic Hospital, Uppsala